Story perspectives

Breakthrough Nasal Vaccine Shows Promise Against COVID-19

9/7/2025

Summary

Story summary

A study from the Centenary Institute and the University of Sydney indicates a nasal vaccine may improve COVID-19 protection by targeting the virus in the nose.
Tested on mice, it demonstrated strong immune responses and boosted effects post-standard vaccinations.
Researchers highlight its potential to lower transmission and severe illness rates.
A University of Pennsylvania study found myth-followed-by-fact messaging increased booster intentions among vaccinated individuals.
UF scientists' universal cancer vaccine shows promise in activating immune responses against silent tumors, with human trials upcoming.

1 of 1

Story summary

A study from the Centenary Institute and the University of Sydney indicates a nasal vaccine may improve COVID-19 protection by targeting the virus in the nose.
Tested on mice, it demonstrated strong immune responses and boosted effects post-standard vaccinations.
Researchers highlight its potential to lower transmission and severe illness rates.
A University of Pennsylvania study found myth-followed-by-fact messaging increased booster intentions among vaccinated individuals.
UF scientists' universal cancer vaccine shows promise in activating immune responses against silent tumors, with human trials upcoming.